Evidence map›Paper›PMID 20562914›Full record

ArticleOncogene2010

Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis.

A S Liss, R Tiwari, J Kralova, H R Bose

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Inhibition of v-Viruses · 2018
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

A S LissSection of Molecular Genetics and Microbiology, Institute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712-1095, USA.
R Tiwari
J Kralova
H R Bose
The University of Texas at Austin · USCzech Academy of Sciences, Institute of Molecular Genetics · CZ

Funding

Transformation by Reticuloendotheliosis VirusR01CA033192 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI BOSE, HENRY R · 1985 to 2011
$3.0M
Mechanism of oncogenesis by Rel/NF-kappaBR01CA098151 · NCI · UNIVERSITY OF TEXAS AUSTIN · PI BOSE, HENRY R · 2003 to 2007
$1.5M
NCI NIH HHS CA098151NCI NIH HHS CA33192NCI NIH HHS R01 CA033192NCI NIH HHS R01 CA098151
6 · The paper itself

Abstract

Cell transformation by the v-rel oncogene is mediated by the aberrant expression of genes that are normally tightly regulated by other Rel/NF-kappaB family members. Although a number of genes inappropriately activated or suppressed by v-Rel have been identified, their contributions to the v-Rel transformation process have been poorly characterized. Here, we examine the role of individual AP-1 proteins in v-Rel-mediated transformation. v-Rel-transformed cells exhibit elevated RNA and protein expression of c-Fos, c-Jun and ATF2 and sustained repression of Fra-2. c-Fos and c-Jun are essential in both the initiation and maintenance of v-Rel-mediated transformation, whereas Fra-2 is dispensable. By employing a c-Jun dimerization mutant, we further identified Fos/Jun heterodimers as major contributors to the v-Rel transformation process. The inability of c-Rel to induce the expression of c-Fos and c-Jun contributes to its weaker oncogenic potential relative to v-Rel. Our studies also demonstrate that v-Rel may induce AP-1 members by directly upregulating gene expression (c-fos and ATF2) and by activating pathways that stimulate AP-1 activity. Although elevated expression of ATF2 is also required for v-Rel-mediated transformation, its ectopic overexpression is inhibitory. Investigating the mode of ATF2 regulation revealed a positive feedback mechanism whereby ATF2 induces p38 MAPK phosphorylation to further induce its own activity. In addition, these studies identified Ha-Ras as an effector of v-Rel-mediated transformation and reveal a novel role for ATF2 in the inhibition of the Ras-Raf-MEK-ERK signaling pathway. Overall, these studies reveal distinct and complex roles of AP-1 proteins in Rel/NF-kappaB oncogenesis.

Indexed as

Cell Transformation, NeoplasticActivating Transcription Factor 2AnimalsCell LineCells, CulturedChick EmbryoDNAExtracellular Signal-Regulated MAP KinasesGene Expression RegulationHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesNF-kappa BOncogene Proteins v-relProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junActivating Transcription Factor 2DNAExtracellular Signal-Regulated MAP KinasesMitogen-Activated Protein Kinase KinasesNF-kappa BOncogene Proteins v-relProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junProto-Oncogene Proteins p21(ras)raf KinasesTranscription Factor AP-1

Identifiers

PMID20562914
PMCPMC2932816
OpenAlexW2068546126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.